1 MONTELUKAST SODIUM | 610 of 790 | 380 prescriptions Less than 1% of all prescriptions | 380 | 160 patients 11% of all patients | 160 patients 11% of all patients | |
2 SYMBICORT (BUDESONIDE/FORMOTEROL FUMARATE) | 160 of 610 | 530 prescriptions Less than 1% of all prescriptions | 530 | 170 patients 12% of all patients | 170 patients 12% of all patients | |
3 AZELASTINE HCL | 360 of 720 | 430 prescriptions Less than 1% of all prescriptions | 430 | 240 patients 17% of all patients | 240 patients 17% of all patients | |
4 FLUTICASONE PROPIONATE | 420 of 740 | 420 prescriptions Less than 1% of all prescriptions | 420 | 140 patients 10% of all patients | 140 patients 10% of all patients | |
5 BREO ELLIPTA (FLUTICASONE/VILANTEROL) | 240 of 550 | 350 prescriptions Less than 1% of all prescriptions | 350 | < 11 | < 11 | |
6 IPRATROPIUM BROMIDE | 360 of 530 | 230 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
7 OLOPATADINE HCL | 120 of 250 | 140 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
8 DYMISTA (AZELASTINE/FLUTICASONE) | 70 of 220 | 170 prescriptions Less than 1% of all prescriptions | 170 | < 11 | < 11 | |
9 ADVAIR HFA (FLUTICASONE PROPION/SALMETEROL) | 240 of 350 | 140 prescriptions Less than 1% of all prescriptions | 140 | < 11 | < 11 | |
10 XOLAIR (OMALIZUMAB) | 110 of 210 | 140 prescriptions Less than 1% of all prescriptions | 140 | < 11 | < 11 | |
11 PROAIR HFA (ALBUTEROL SULFATE) | 250 of 510 | 210 prescriptions Less than 1% of all prescriptions | 210 | < 11 | < 11 | |
12 FLOVENT HFA (FLUTICASONE PROPIONATE) | 210 of 320 | 120 prescriptions Less than 1% of all prescriptions | 120 | < 11 | < 11 | |
13 VENTOLIN HFA (ALBUTEROL SULFATE) | 390 of 560 | 130 prescriptions Less than 1% of all prescriptions | 130 | < 11 | < 11 | |
14 PREDNISONE | 380 of 590 | 260 prescriptions Less than 1% of all prescriptions | 260 | 250 patients 17% of all patients | 250 patients 17% of all patients | |
15 AZITHROMYCIN | 90 of 300 | 230 prescriptions Less than 1% of all prescriptions | 230 | 200 patients 14% of all patients | 200 patients 14% of all patients | A |